Literature DB >> 26214026

Influence of intensive multifunctional neurorehabilitation on neuronal oxidative damage in patients with Huntington's disease.

Irene Ciancarelli, Daniela De Amicis, Caterina Di Massimo, Giorgio Sandrini, Caterina Pistarini, Antonio Carolei, Maria Giuliana Tozzi Ciancarelli.   

Abstract

The influence of intensive multifunctional neurorehabilitation on serum levels of Cu/Zn-superoxide dismutase (Cu/Zn-SOD), neuron-specific enolase (NSE), and 8-hydroxy-2-deoxyguanosine (8-OHdG), as markers of oxidative damage, was evaluated in symptomatic patients with Huntington's disease (HD). Improved clinical outcome measures were observed after neurorehabilitation. Baseline levels of Cu/Zn-SOD, NSE and 8-OHdG were higher than those observed in controls. Cu/Zn-SOD and NSE values decreased after neurorehabilitation, but were still higher than those measured in controls. Cu/Zn-SOD and NSE correlated positively before (r=0.659; p=0.003) and after rehabilitation (r=0.553, p=0.017). 8-OHdG values decreased after neurorehabilitation without reaching significance when compared with baseline values (p=0.145). No correlation was observed between the measured oxidative markers and the assessed clinical outcome measures, either before or after neurorehabilitation. The findings reported in the present paper provide evidence of the effectiveness of neurorehabilitation in reducing oxidative damage in HD patients and underline the limit of serum oxidative markers for the evaluation of clinical features of HD.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26214026      PMCID: PMC4520671     

Source DB:  PubMed          Journal:  Funct Neurol        ISSN: 0393-5264


  40 in total

Review 1.  Antioxidants in Huntington's disease.

Authors:  Ashu Johri; M Flint Beal
Journal:  Biochim Biophys Acta       Date:  2011-11-23

2.  Oxidative stress in post-acute ischemic stroke patients after intensive neurorehabilitation.

Authors:  Irene Ciancarelli; Daniela De Amicis; Caterina Di Massimo; Antonio Carolei; Maria Giuliana Tozzi Ciancarelli
Journal:  Curr Neurovasc Res       Date:  2012-11       Impact factor: 1.990

3.  Effect of endurance exercise training on the expression of GFAP, S100B, and NSE in the striatum of chronic/progressive mouse model of Parkinson's disease.

Authors:  Muhammed D Al-Jarrah; Mohammed Jamous
Journal:  NeuroRehabilitation       Date:  2011       Impact factor: 2.138

4.  8-OHdG: its (limited) potential as a biomarker for Huntington's disease.

Authors:  Annie Killoran; Kevin M Biglan
Journal:  Biomark Med       Date:  2012-12       Impact factor: 2.851

5.  Evidence-based guideline: pharmacologic treatment of chorea in Huntington disease: report of the guideline development subcommittee of the American Academy of Neurology.

Authors:  Melissa J Armstrong; Janis M Miyasaki
Journal:  Neurology       Date:  2012-07-18       Impact factor: 9.910

6.  Huntington disease: functional capacities in patients treated with neuroleptic and antidepressant drugs.

Authors:  I Shoulson
Journal:  Neurology       Date:  1981-10       Impact factor: 9.910

7.  Physical therapy in Huntington's disease--toward objective assessments?

Authors:  S Bohlen; C Ekwall; K Hellström; H Vesterlin; M Björnefur; L Wiklund; R Reilmann
Journal:  Eur J Neurol       Date:  2012-06-04       Impact factor: 6.089

8.  Physical training exerts neuroprotective effects in the regulation of neurochemical factors in an animal model of Parkinson's disease.

Authors:  T Tuon; S S Valvassori; J Lopes-Borges; T Luciano; C B Trom; L A Silva; J Quevedo; C T Souza; F S Lira; R A Pinho
Journal:  Neuroscience       Date:  2012-10-03       Impact factor: 3.590

9.  The influence of gender on phenotype and disease progression in patients with Huntington's disease.

Authors:  Daniel Zielonka; Johan Marinus; Raymund A C Roos; Giuseppe De Michele; Stefano Di Donato; Hein Putter; Jerzy Marcinkowski; Ferdinando Squitieri; Anna Rita Bentivoglio; G Bernhard Landwehrmeyer
Journal:  Parkinsonism Relat Disord       Date:  2012-10-25       Impact factor: 4.891

10.  8OHdG is not a biomarker for Huntington disease state or progression.

Authors:  Beth Borowsky; John Warner; Blair R Leavitt; Sarah J Tabrizi; Raymund A C Roos; Alexandra Durr; Chris Becker; Cristina Sampaio; Allan J Tobin; Howard Schulman
Journal:  Neurology       Date:  2013-04-24       Impact factor: 9.910

View more
  7 in total

1.  Ameliorative Role of Cerium Oxide Nanoparticles Against Fipronil Impact on Brain Function, Oxidative Stress, and Apoptotic Cascades in Albino Rats.

Authors:  Norhan Elshony; Atef M K Nassar; Yasser S El-Sayed; Dalia Samak; Ahmed Noreldin; Lamiaa Wasef; Hamida Saleh; Yaser H A Elewa; Shereen E Tawfeek; Abdullah A Saati; Gaber El-Saber Batiha; Michał Tomczyk; Masakazu Umezawa; Hazem M Shaheen
Journal:  Front Neurosci       Date:  2021-05-14       Impact factor: 4.677

Review 2.  What, When and How to Measure-Peripheral Biomarkers in Therapy of Huntington's Disease.

Authors:  Lukasz Przybyl; Magdalena Wozna-Wysocka; Emilia Kozlowska; Agnieszka Fiszer
Journal:  Int J Mol Sci       Date:  2021-02-04       Impact factor: 5.923

Review 3.  Oxidative Stress in Neurodegenerative Diseases: From Molecular Mechanisms to Clinical Applications.

Authors:  Zewen Liu; Tingyang Zhou; Alexander C Ziegler; Peter Dimitrion; Li Zuo
Journal:  Oxid Med Cell Longev       Date:  2017-07-12       Impact factor: 6.543

Review 4.  New Insights into the Role of Neuron-Specific Enolase in Neuro-Inflammation, Neurodegeneration, and Neuroprotection.

Authors:  Azizul Haque; Rachel Polcyn; Denise Matzelle; Naren L Banik
Journal:  Brain Sci       Date:  2018-02-18

Review 5.  Exercise in Huntington's Disease: Current State and Clinical Significance.

Authors:  Sandro Manuel Mueller; Jens A Petersen; Hans H Jung
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2019-02-04

6.  Rehabilitation outcomes in Huntington disease patients with low body mass index.

Authors:  Irene Ciancarelli; Giovanni Morone; Marco Iosa; Stefano Paolucci; Loris Pignolo; Paolo Tonin; Antonio Cerasa; Maria Giuliana Tozzi Ciancarelli
Journal:  J Musculoskelet Neuronal Interact       Date:  2022-03-01       Impact factor: 1.864

Review 7.  A Critical Evaluation of Wet Biomarkers for Huntington's Disease: Current Status and Ways Forward.

Authors:  Edina Silajdžić; Maria Björkqvist
Journal:  J Huntingtons Dis       Date:  2018
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.